Back to Search Start Over

A Phase 1 randomized study of GSK3732394, an investigational long-acting biologic treatment regimen for HIV-1 infection.

Authors :
Krystal, Mark
Chabria, Shiven
Austin, Daren
Wolstenholme, Allen
Wensel, David
Lataillade, Max
Abberbock, Judah
Baker, Mark
Ackerman, Peter
Source :
Antiviral Therapy; Oct2022, Vol. 27 Issue 5, p1-10, 10p
Publication Year :
2022

Details

Language :
English
ISSN :
13596535
Volume :
27
Issue :
5
Database :
Complementary Index
Journal :
Antiviral Therapy
Publication Type :
Academic Journal
Accession number :
159949361
Full Text :
https://doi.org/10.1177/13596535221131164